Thrivent Financial for Lutherans
NRIX icon

Thrivent Financial for Lutherans’s Nurix Therapeutics NRIX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,177
Closed -$135K – 2512
2023
Q1 		$135K Hold
15,177
– – ﹤0.01% 2401
2022
Q4 		$167K Hold
15,177
– – ﹤0.01% 2369
2022
Q3 		$198K Hold
15,177
– – ﹤0.01% 2344
2022
Q2 		$192K Buy
+15,177
New +$192K ﹤0.01% 2360